Pfizer has denied doing gain-of-function research but also said it was engineering the virus to express variant spike proteins. Now Dr. Paul Offit has implied that such work is indeed gain-of-function research.
The post FDA Adviser Inadvertently Confirms Pfizer is Doing Gain-of-Function Research appeared first on The Daily Sceptic.